VEGF inhibitors prevent angiogenesis and were associated with decreased nitric oxide production, vasoconstriction and hypertension [12,14], thus potentiating endothelial dysfunction, atherosclerosis and thrombotic microangiopathy [15,16]. This evidence concerns the gene VEGFA and Hypertension.